Tanja Villumsen

Tanja Villumsen is an experienced professional in the field of clinical supplies and pharmaceutical sciences, currently serving as the Head of Department for Clinical Supplies at Novo Nordisk since September 2012, focusing on stem cell-based projects and aiming for successful clinical execution in preparation for FPFT in 2025. Tanja has held various roles within Novo Nordisk, contributing significantly to clinical supply management across multiple R&D projects. In addition to ongoing responsibilities, Tanja is actively involved in several boards, including as Vice Chairman of the Board for Pharmadanmark and a member of Women in Life Science Denmark, championing the life science sector in Denmark. Tanja’s educational background includes a Master’s Degree in Pharmaceutical Sciences from the University of Copenhagen and a Graduate Certificate in Business Administration from Copenhagen Business School, complemented by recent board training.